Emerging Practice Strategies for PI3K Inhibitors in Relapsed/Refractory Follicular Lymphoma

episode

Keeping Current CME not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

The Most Miserable Festival In America 27 min · 27 Sep 2026 · Layze

NPR News: 09-27-2026 10AM EDT 4 min · 27 Sep 2026 · NPR News Now

10AM ET 09/27/2026 Newscast 3 min · 27 Sep 2026 · Fox News Hourly Update

Find a man who can pitch a tent (and hello to our troll!) 34 min · 27 Sep 2026 · Steph & Laura

What to do with Taylor Frankie Paul...? 43 min · 27 Sep 2026 · Shameless

Time Theft 14 min · 27 Sep 2026 · The Art of Decluttering

Report any issue

Source

Recorded08 Jun 2021

Publisherkeepingcurrentcme.libsyn.com ↗

Handlerec:4300006

Show notes

Dr Nastoupil and Dr Dreyling discuss PI3K inhibition in follicular lymphoma, including practical considerations and treatment selection. Credit available for this activity expires: 6/7/2022 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/952387?src=mkm_podcast_addon_952387

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in